- Home
- PYPD vs CCM Comparison
PYPD vs CCM Comparison
Compare PYPD & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- CCM
- Stock Information
- Founded
- PYPD 2008
- CCM 1997
- Country
- PYPD Israel
- CCM China
- Employees
- PYPD N/A
- CCM N/A
- Industry
- PYPD Medical/Dental Instruments
- CCM Medical/Nursing Services
- Sector
- PYPD Health Care
- CCM Health Care
- Exchange
- PYPD Nasdaq
- CCM Nasdaq
- Market Cap
- PYPD 24.2M
- CCM 25.1M
- IPO Year
- PYPD 2020
- CCM 2009
- Fundamental
- Price
- PYPD $3.56
- CCM $5.04
- Analyst Decision
- PYPD Strong Buy
- CCM
- Analyst Count
- PYPD 2
- CCM 0
- Target Price
- PYPD $12.00
- CCM N/A
- AVG Volume (30 Days)
- PYPD 8.1K
- CCM 6.1K
- Earning Date
- PYPD 11-13-2024
- CCM 11-29-2024
- Dividend Yield
- PYPD N/A
- CCM N/A
- EPS Growth
- PYPD N/A
- CCM N/A
- EPS
- PYPD N/A
- CCM N/A
- Revenue
- PYPD N/A
- CCM $64,910,622.00
- Revenue This Year
- PYPD N/A
- CCM N/A
- Revenue Next Year
- PYPD N/A
- CCM N/A
- P/E Ratio
- PYPD N/A
- CCM N/A
- Revenue Growth
- PYPD N/A
- CCM N/A
- 52 Week Low
- PYPD $2.95
- CCM $3.80
- 52 Week High
- PYPD $9.20
- CCM $26.70
- Technical
- Relative Strength Index (RSI)
- PYPD 54.93
- CCM 30.42
- Support Level
- PYPD $3.30
- CCM $4.47
- Resistance Level
- PYPD $3.59
- CCM $5.50
- Average True Range (ATR)
- PYPD 0.21
- CCM 0.69
- MACD
- PYPD 0.02
- CCM -0.27
- Stochastic Oscillator
- PYPD 68.27
- CCM 12.39
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.